Chemomab Therapeutics (CMMB) Q4 2023 Earnings

7MarConfirmed
Q4 2022
Q2 2023
Q3 2023
Q4 2023
-0.72
-0.49
-0.25
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.26
Surprise EPS
-0.26
Surprise Percent
+∞%

Description

Chemomab Therapeutics (CMMB) has reported earnings of -0.26 per share for Q4 2023.

0 Comments

Share your thoughts